7I1C
PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment E11 from the F2X-Entry Screen in orthorhombic space group
Summary for 7I1C
Entry DOI | 10.2210/pdb7i1c/pdb |
Group deposition | PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragments from the F2X-Entry Screen in orthorhombic space group (G_1002335) |
Descriptor | 3C-like proteinase nsp5, CHLORIDE ION, [2-(morpholin-4-yl)-1,3-thiazol-5-yl]methanol, ... (4 entities in total) |
Functional Keywords | sars-cov-2, fragment screen, main protease, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 2 |
Total formula weight | 67922.26 |
Authors | Barthel, T.,Benz, L.S.,Wollenhaupt, J.,Weiss, M.S. (deposition date: 2025-02-03, release date: 2025-05-21) |
Primary citation | Barthel, T.,Wollenhaupt, J.,Benz, L.S.,Reincke, P.,Zhang, L.,Lennartz, F.,Tabermann, H.,Mueller, U.,Meente, A.,Hilgenfeld, R.,Weiss, M.S. Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening To be published, |
Experimental method | X-RAY DIFFRACTION (1.95 Å) |
Structure validation
Download full validation report
